Patents by Inventor Brian Edward Collins

Brian Edward Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150147317
    Abstract: The present invention relates to the characterization and production of bevacizumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 28, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20150141620
    Abstract: The present invention relates to the characterization and production of rituximab.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 21, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20150140608
    Abstract: The present invention relates to the characterization and production of omalizumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 21, 2015
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Patent number: 9029081
    Abstract: The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: May 12, 2015
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Ian Christopher Parsons, Dorota A. Bulik, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Brian Edward Collins
  • Publication number: 20150125848
    Abstract: The present invention relates to the characterization and production of alemtuzumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 7, 2015
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20150104444
    Abstract: The present invention relates to the characterization and production of trastuzumab. The present disclosure provides, in part, methods for evaluating, identifying, and/or producing (e.g., manufacturing) trastuzumab. In some instances, methods herein allow highly resolved evaluation of trastuzumab useful for, inter alia, manufacturing trastuzumab, characterizing trastuzumab, identifying and/or confirming trastuzumab, monitoring the structure of trastuzumab, comparing trastuzumab preparations made over time or made under different conditions, and/or controlling the structure of trastuzumab.
    Type: Application
    Filed: May 31, 2013
    Publication date: April 16, 2015
    Inventors: John Robblee, Brian Edward Collins, Ganesh Kaundinya, Carlos J. Bosques
  • Publication number: 20140274911
    Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using ammonium and/or lysine, are described.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Brian Edward Collins, Holly Prentice, Brett Belongia, Rasheed Tijani
  • Publication number: 20140112910
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Application
    Filed: May 18, 2012
    Publication date: April 24, 2014
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Publication number: 20130231255
    Abstract: Methods and compositions related to high mannose glycans are described.
    Type: Application
    Filed: April 7, 2011
    Publication date: September 5, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Brian Edward Collins, Jay Duffner, Carlos J. Bosques, Dorota A. Bulik, James Myette, James Meador
  • Publication number: 20130123126
    Abstract: A method of making a glycoprotein having a selected glycostructure.
    Type: Application
    Filed: April 7, 2011
    Publication date: May 16, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Brian Edward Collins, Jay Duffner, Victor Farutin, Naveen Bhatnagar, Lakshmanan Thiruneelakantapillai, Carlos J. Bosques, Ganesh Kaundinya
  • Patent number: 8361705
    Abstract: The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.
    Type: Grant
    Filed: April 15, 2008
    Date of Patent: January 29, 2013
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Ian Christopher Parsons, Dorota A. Bulik, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Brian Edward Collins
  • Publication number: 20120329709
    Abstract: The present invention provides methods and materials by which glycosylation of glycoproteins can be regulated. Methods include the monitoring and regulation of parameters such that a glycoprotein having a desired product quality is obtained.
    Type: Application
    Filed: May 25, 2010
    Publication date: December 27, 2012
    Inventors: Brian Edward Collins, Tiffany Guo, Lakshmanan Thiruneelakantapillai, Kevin Millea, Dorota A. Bulik
  • Patent number: 8338088
    Abstract: The present disclosure provides methods for assessing the glycosylation of a target glycoprotein produced by a cell through analysis of cell-surface glycans on the cell. The present disclosure therefore teaches that glycosylation of cell surface proteins can serve as a proxy for glycosylation of other proteins.
    Type: Grant
    Filed: April 15, 2008
    Date of Patent: December 25, 2012
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Carlos J. Bosques, Xiangping Zhu, Dorota A. Bulik, Lakshmanan Thiruneelakantapillai, Ian Christopher Parsons, Zachary Shriver, Rajeev Chillakuru, Ganesh Venkataraman
  • Publication number: 20120264927
    Abstract: Methods for labeling glycans that include a step of freeze-drying a labeled glycan preparation. The labeled glycan preparation is maintained in a substantially frozen state for the duration of the freeze-drying process.
    Type: Application
    Filed: April 15, 2008
    Publication date: October 18, 2012
    Inventors: Ian Christopher Parsons, Lakshmanan Thiruneelakantapillai, Carlos J. Bosques, Brian Edward Collins
  • Publication number: 20110213137
    Abstract: The present disclosure provides methods of making isotopically-labeled glycans or a mixture of glycans (e.g., a glycan preparation) via reductive amination. Such methods are useful, for example, in the determination of the relative amounts of a glycan species present in two or more glycoprotein preparations using mass spectroscopy. In one aspect, the present disclosure provides a method of making an isotopically-labeled glycan by a glycan with an amine and an isotopically-labeled reducing agent to provide an isotopically-labeled aminated glycan. In certain embodiments, the amine is an isotopically-labeled amine.
    Type: Application
    Filed: April 15, 2008
    Publication date: September 1, 2011
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Carlos J. Bosques, Ian Christopher Parsons, Lakshmanan Thiruneelakantapillai, Brian Edward Collins, Hetal Sarvaiya
  • Publication number: 20100196940
    Abstract: The present disclosure provides methods for assessing the glycosylation of a target glycoprotein produced by a cell through analysis of cell-surface glycans on the cell. The present disclosure therefore teaches that glycosylation of cell surface proteins can serve as a proxy for glycosylation of other proteins.
    Type: Application
    Filed: April 15, 2008
    Publication date: August 5, 2010
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Brian Edward Collins, Carlos J. Bosques, Xiangping Zhu, Dorota A. Bulik, Lakshmanan Thiruneelakantapillai, Ian Christopher Parsons, Zachary Shriver, Rajeev Chillakuru, Ganesh Venkataraman
  • Publication number: 20100151499
    Abstract: The present disclosure provides strategies for analyzing protein-linked glycans, and particularly for analyzing glycans on cell surface glycoproteins.
    Type: Application
    Filed: April 15, 2008
    Publication date: June 17, 2010
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Dorota A. Bulik, Carlos J. Bosques, Ian Christopher Parsons
  • Publication number: 20100129843
    Abstract: The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.
    Type: Application
    Filed: April 15, 2008
    Publication date: May 27, 2010
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Ian Christopher Parsons, Dorota A. Bulik, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Brian Edward Collins
  • Publication number: 20100113294
    Abstract: The invention provides methods, databases and systems for making glycoprotein products having defined properties.
    Type: Application
    Filed: April 15, 2008
    Publication date: May 6, 2010
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Ganesh Venkataraman, Brian Edward Collins, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Dorota A. Bulik, Ian Christopher Parsons, Zachary Shriver, Rajeev Chillakuru
  • Publication number: 20100051887
    Abstract: A wire strainer has a ratcheted spool rotatably attached to a frame to rotate in a desired direction when tensioning and able to freewheel otherwise. At least one oval/elliptical hole in the shaft accommodates one, two or more wires therein in a particular orientation on the shaft. The oval/elliptical hole is adapted to be dimensioned and positioned on the shaft such that the integrity and strength of the shaft is not compromised or lessened. A projection and a two plane guide means can be situated on the spool whereby the projection is positioned and engages with a portion of a wire and the two plane guide is positioned and assists in deflecting the length of wire not engaged with the projection away from the projection as the spool is rotated during the straining of a wire. Y-shaped reinforcing ribs on the frame provide strengthening and rigidity while tensioning.
    Type: Application
    Filed: August 24, 2009
    Publication date: March 4, 2010
    Applicant: ROBERTSON ENGINEERING LIMITED
    Inventors: MAURICE WILLIAM WOOSTER, BRIAN EDWARD COLLINS